Gossamer Bio (GOSS) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$1.4 billion.
- Gossamer Bio's Retained Earnings fell 1263.91% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 1263.91%. This contributed to the annual value of -$1.3 billion for FY2024, which is 466.39% down from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's Retained Earnings is -$1.4 billion, which was down 1263.91% from -$1.3 billion recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Retained Earnings ranged from a high of -$860.6 million in Q1 2022 and a low of -$1.4 billion during Q3 2025
- Its 4-year average for Retained Earnings is -$1.2 billion, with a median of -$1.2 billion in 2024.
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 2565.21% in 2023, then tumbled by 408.34% in 2025.
- Over the past 4 years, Gossamer Bio's Retained Earnings (Quarter) stood at -$1.0 billion in 2022, then fell by 17.42% to -$1.2 billion in 2023, then decreased by 4.66% to -$1.3 billion in 2024, then fell by 9.71% to -$1.4 billion in 2025.
- Its last three reported values are -$1.4 billion in Q3 2025, -$1.3 billion for Q2 2025, and -$1.3 billion during Q1 2025.